Chronic inflammation and cellular senescence: why they accelerate aging

There are processes that make no noise, and chronic low-grade inflammation is among the most silent: no fever, no swollen joints, no signal strong enough to prompt testing. It works for years below the threshold of perception while modifying the way cells age.

At IMAGE REGENERATIVE, in Milano and St. Moritz, the longevity medicine pathway begins with measuring these silent processes, long before they become a diagnosis.

Chronic inflammation and cellular senescence are two distinct phenomena that fuel each other. Understanding how they intertwine is the most concrete way to explain why two people of the same chronological age can have very different biological ages.

What is chronic inflammation

Inflammation is a necessary response, and in its acute form represents one of the most efficient defense mechanisms of the organism. Faced with an infection or trauma, tissue recruits immune cells, increases vascular permeability and activates repair processes. Redness, heat, swelling and pain appear, and when the cause is removed the response subsides.

Chronic low-grade inflammation works in a completely different way. It is defined as chronic because it persists over time, systemic because it involves the entire organism instead of a single area, sterile because it does not depend on an identifiable infection, and low-grade because markers are altered slightly but constantly. None of the classic signs appear, and precisely this absence makes it difficult to detect without looking for it.

On a laboratory level it translates to persistently elevated values of high-sensitivity C-reactive protein, interleukin 6 and tumor necrosis factor alpha. On a subjective level, when something is felt, these are generic symptoms that rarely lead to the doctor, such as fatigue that rest does not resolve, unrefreshing sleep, diffuse muscle pain and slower recovery after physical activity.

Cellular senescence: cells that age

Cellular senescence is a stable arrest of the division cycle. The cell remains alive and metabolically active, continues to occupy its place in the tissue, but permanently stops replicating. The triggers are diverse and often concurrent, including progressive telomere shortening with each division, accumulated DNA damage, oxidative stress and abnormal oncogene activation.

It is worth emphasizing that this is a useful mechanism, at least originally. Blocking the division of a damaged cell prevents the error from propagating, and for this reason senescence represents one of the main natural barriers against tumor transformation. The same process intervenes in wound healing and embryonic development.

A less intuitive aspect concerns distribution. Senescent cells concentrate in tissues subjected to greater turnover or greater mechanical and metabolic stress, such as sun-exposed skin, vascular endothelium, articular cartilage and visceral adipose tissue. This is why the same areas tend to manifest the first signs of aging, and why skin appearance and joint condition are often the first indicators to become visible.

The problem arises from accumulation. In a young organism senescent cells are recognized and removed by the immune system, particularly by natural killer cells and macrophages. With age this surveillance loses efficiency, clearance slows and senescent cells deposit in tissues in increasing numbers. They have been nicknamed zombie cells precisely for this reason, because they remain present and active, unable to renew themselves and increasingly difficult to remove.

Inflammaging: when inflammation and aging combine

The term inflammaging was coined in 2000 by Italian immunologist Claudio Franceschi to describe the progressive increase in pro-inflammatory status that accompanies aging, in the absence of any ongoing infection. It is the synthesis of two words and two processes that, observed together, explain much more than they explain separately.

The bridge between the two phenomena has a precise name, the senescence-associated secretory phenotype, abbreviated as SASP. Senescent cells, despite having stopped dividing, continuously secrete a set of inflammatory molecules, including interleukin 6, interleukin 1 beta, tumor necrosis factor alpha and metalloproteases capable of degrading the extracellular matrix.

This is where the most insidious effect arises. These molecules also act on neighboring healthy cells, pushing them in turn toward senescence through a paracrine mechanism, which transforms a local phenomenon into a chain progression. More senescent cells means more inflammatory signaling, and more inflammation means more senescent cells. Inflammaging is now associated with the development of atherosclerosis, adult-onset diabetes, chronic kidney disease, cardiovascular diseases and neurodegenerative diseases.

How chronic inflammation accelerates aging

The transition from molecular mechanism to clinic becomes evident when observed tissue by tissue. In arteries inflammatory cytokines activate the endothelium, promote lipoprotein oxidation and accelerate plaque formation, in a process that precedes the cardiovascular event by decades.

In skeletal muscle the same signal shifts the balance toward protein catabolism and contributes to sarcopenia, that is, the progressive loss of mass and strength that conditions autonomy in later years. In bone the activation of osteoclasts reduces mineral density. In the central nervous system activated microglia maintain a state of neuroinflammation that interferes with synaptic plasticity.

On the skin the mechanism is particularly readable, because the result is visible. The metalloproteases released by SASP degrade collagen and elastin faster than fibroblasts can rebuild them, so the dermis thins, tissue loses compactness, wounds heal more slowly and aesthetic treatments deliver less than expected. This is why, in a serious regenerative pathway, skin quality is read as a systemic indicator and not only as a local matter.

From this derives the gap between chronological age and biological age. The first is counted in years and proceeds equally for everyone, while the second describes the functional state of tissues and depends largely on the accumulated inflammatory load. Two people born on the same day can be years apart on the biological level, and the difference is built slowly, through daily decisions that seem irrelevant in the short term. It is also encouraging news, because the modifiable component of this process is broad and remains so at any age.

Risk factors: diet, stress and lifestyle

In clinical practice the modifiable determinants of chronic low-grade inflammation are few and recurring:

• A high glycemic load diet, rich in refined sugars and industrial fats, which sustains oxidative stress and alters intestinal microbiota composition.
• Visceral adiposity, metabolically active tissue that directly produces inflammatory cytokines even in people with apparently normal body weight.
• Insufficient or fragmented sleep, which misaligns circadian rhythms and keeps inflammatory markers elevated in the morning hours.
• Prolonged psychological stress, which through chronically high cortisol reduces tissue sensitivity to the physiological anti-inflammatory signal.
• Sedentary lifestyle combined with smoking, a combination that reduces muscle mass and increases systemic oxidative load.

Alongside these act less known but far from marginal factors. Intestinal dysbiosis, with increased barrier permeability, releases bacterial fragments into circulation that feed the immune response. Localized chronic inflammations, such as periodontal disease, contribute to the overall load. Prolonged exposure to atmospheric pollutants and ultraviolet radiation completes the picture. None of these elements alone is determinant, while their sum over time becomes so.

How to reduce inflammation and protect cells

The first step is to measure, because a process that gives no symptoms is only addressed if made visible. A precision assessment combines high-sensitivity C-reactive protein, glycemic and insulinemic profile, lipid profile, vitamin D, homocysteine and body composition, returning a snapshot of the inflammatory load the patient carries.

The most effective levers remain those of lifestyle, and must be stated without rhetoric. A low glycemic load diet, rich in polyphenols, fiber and omega 3 fatty acids, measurably reduces inflammatory markers, and this is why the Mediterranean diet is considered a protective factor. Strength training deserves particular emphasis, because muscle behaves as an endocrine organ and during contraction releases myokines with systemic anti-inflammatory action. To complete the picture are sleep regularization and active stress management, together with a nutritional pathway based on collected data.

On the medical level there are tools that support this work, from regenerative IV therapies with glutathione to intravenous NAD+ therapy, used to support mitochondrial function and DNA repair mechanisms. However, an honest clarification is needed, one that distinguishes a serious pathway from a promise. No therapy currently available eliminates inflammation or selectively removes senescent cells in humans. Senolytics remain an active research field, and what can be done is reduce the load, slow its accumulation and protect the regenerative capacity of tissues. This is the difference, which we have addressed elsewhere, between guided longevity and the promise of a miracle.

Frequently asked questions

What is inflammaging?

It is chronic, systemic, low-grade inflammation that accompanies aging in the absence of infection. The term was introduced in 2000 and describes the link between accumulation of senescent cells, continuous release of cytokines and appearance of age-related diseases.

How is chronic inflammation measured?

Through a panel of tests that includes high-sensitivity C-reactive protein, complete blood count, glucose and insulin with insulin resistance index, lipid profile, vitamin D and homocysteine. The single value says little: it is the overall reading, repeated over time, that returns the trend.

Can senescent cells be removed?

The organism does this naturally through the immune system, with an efficiency that decreases with age. Senolytic drugs, studied precisely to promote this removal, are still the subject of clinical research and are not currently part of standard practice.

Does anti-inflammatory diet really work?

Yes, with a clarification. The effect on inflammatory markers is documented and measurable, but requires continuity in the order of months and works much better when combined with regular physical activity, adequate sleep and control of visceral adiposity.